STATHalf of cancer drugs given accelerated approval fail in later trials | STATApr 7Jonathan E. WosenBy Jonathan E. Wosenmore_vert
The Associated PressMany cancer drugs remain unproven 5 years after accelerated approval, a study findsApr 7Carla JohnsonBy Carla Johnsonmore_vert
CBS NewsMany cancer drugs remain unproven years after FDA's accelerated approval, study findsApr 9more_vert